表紙
市場調查報告書

血管分枝病變的全球市場:用途·地區·各領域的未來預測

Bifurcation Lesions Market Analysis By Application (Coronary Vascular and Peripheral Vascular), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 557181
出版日期 內容資訊 英文 90 Pages
商品交期: 2-3個工作天內
價格
Back to Top
血管分枝病變的全球市場:用途·地區·各領域的未來預測 Bifurcation Lesions Market Analysis By Application (Coronary Vascular and Peripheral Vascular), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014 - 2025
出版日期: 2017年08月09日內容資訊: 英文 90 Pages
簡介

本報告提供全球血管分枝病變的相關市場相關分析,提供各疾病·治療產品概要和市場基本結構·最新形勢,主要的推動及阻礙市場要素,整體市場規模趨勢預測 (過去3年·今後9年份),各用途·各地區的詳細趨勢,主要企業簡介·業績等調查。

第1章 分析方法·範圍

第2章 摘要整理

第3章 血管分枝病變市場:產業的未來展望

  • 市場區分
  • 產品普及率·市場成長率預測 (總計12年份)
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素分析
  • 優先級高的主要市場機會
  • 波特的五力分析
  • PESTEL分析
  • 市場競爭方案

第4章 血管分枝病變市場:各用途的未來展望

  • 各用途的市場佔有率 (以金額為準,最新值·預測值)
  • 心血管
  • 末稍血管

第5章 血管分枝病變市場:各地區的未來展望

  • 各地區的市場佔有率 (以金額為準,最新值·預測值)
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國)
  • 亞太地區 (日本,中國)
  • 南美 (巴西,墨西哥)
  • 中東·非洲 (南非)

第6章 競爭情形

  • 競爭環境
  • 策略架構

第7章 企業簡介

目錄
Product Code: GVR-1-68038-534-2

The global bifurcation lesions market is expected to reach USD 2.8 billion by 2025, growing at a CAGR of 5.6%, according to a new report by Grand View Research, Inc. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

Increasing geriatric population and unhealthy lifestyle are responsible for growth in incidence of cardiovascular disorders. Furthermore, increase in approval & commercialization of innovative devices and expected entry of new devices for treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Further key findings from the report suggest:

  • Increase in commercialization of devices for bifurcation lesions and investments by industry players for R&D are expected to boost the market, resulting in an anticipated CAGR of around 5% from 2017 to 2025
  • Coronary vascular segment accounted for maximum share of the market in 2016 due to presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • Peripheral vascular segment is likely to witness lucrative growth in the coming years due to increase in investments by industry players for development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2016. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and local presence of major market players.
  • Asia Pacific is expected to observe fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and rise in investments by market players in the region.

Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Bifurcation Lesions Market Industry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market Size and Growth Prospects, 2014 - 2025
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis - Porter's
  • 3.6. PESTEL Analysis, 2016
  • 3.7. Bifurcation Lesions Competitive Scenario, 2016
    • 3.7.1. Competitive landscape/Heat map analysis: Market position analysis (based on product portfolio, regional presence and strategic initiatives)

Chapter 4. Bifurcation Lesions Market: Application Outlook

  • 4.1. Bifurcation Lesions Market Share by Application, 2016 & 2025 (USD Million)
  • 4.2. Coronary Vascular
    • 4.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.2. Market estimates and forecasts by region, 2014 - 2025 (USD Million)
  • 4.3. Peripheral Vascular
    • 4.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.2. Market estimates and forecasts by region, 2014 - 2025 (USD Million)

Chapter 5. Bifurcation Lesions Market: Regional Outlook

  • 5.1. Bifurcation Lesions Market Share by Region, 2016& 2025(USD Million)
  • 5.2. North America
    • 5.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.2.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.2.3. U.S.
      • 5.2.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.2.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.2.4. Canada
      • 5.2.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.2.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
  • 5.3. Europe
    • 5.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.3.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.3.4. U.K.
      • 5.3.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.3.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.4.3. Japan
      • 5.4.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.4.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.4.4. China
      • 5.4.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.4.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.5.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.5.3. Brazil
      • 5.5.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.5.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.5.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.6.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.6.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Competitive Environment
  • 6.2. Strategy Framework

Chapter 7. Company Profiles

  • 7.1. Medtronic
    • 7.1.1. Company overview
    • 7.1.2. Financial performance
    • 7.1.3. Product benchmarking
    • 7.1.4. Strategic initiatives
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Company overview
    • 7.2.2. Financial performance
    • 7.2.3. Product benchmarking
    • 7.2.4. Strategic initiatives
  • 7.3. Johnson& Johnson Services, Inc
    • 7.3.1. Company overview
    • 7.3.2. Financial performance
    • 7.3.3. Product benchmarking
    • 7.3.4. Strategic initiatives
  • 7.4. Abbott
    • 7.4.1. Company overview
    • 7.4.2. Financial performance
    • 7.4.3. Product benchmarking
    • 7.4.4. Strategic initiatives
  • 7.5. C. R. Bard, Inc.
    • 7.5.1. Company overview
    • 7.5.2. Financial performance
    • 7.5.3. Product benchmarking
    • 7.5.4. Strategic initiatives
  • 7.6. Spectranetics
    • 7.6.1. Company overview
    • 7.6.2. Financial performance
    • 7.6.3. Product benchmarking
    • 7.6.4. Strategic initiatives
  • 7.7. Terumo Medical Corporation
    • 7.7.1. Company overview
    • 7.7.2. Financial performance
    • 7.7.3. Product benchmarking
    • 7.7.4. Strategic initiatives
  • 7.8. Cardinal Health
    • 7.8.1. Company overview
    • 7.8.2. Financial performance
    • 7.8.3. Product benchmarking
    • 7.8.4. Strategic initiatives

List of Tables

  • TABLE 1 Bifurcation lesionsmarket estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 2 Bifurcation lesionsmarket estimates and forecast by region, 2014 - 2025 (USD Million)
  • TABLE 3 North America bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 4 North America bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 5 U.S. bifurcation lesionmarket estimates and forecast by application (USD Million)
  • TABLE 6 Canada bifurcation lesionmarket estimates and forecast by application (USD Million)
  • TABLE 7 Europe bifurcation lesionmarket estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 8 Europe bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 9 Germany bifurcation lesionmarket estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 10 U.K. bifurcation lesion market estimates and forecast by application (USD Million)
  • TABLE 11 Asia Pacific bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 12 Asia Pacific bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 13 Japan bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 14 China bifurcation lesion market estimates and forecast by application (USD Million)
  • TABLE 15 Latin America bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 16 Latin America bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 17 Brazil bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 18 Mexico bifurcation lesion market estimates and forecast by application (USD Million)
  • TABLE 19 Middle East & Africa bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 20 Middle East & Africa bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 21 South Africa bifurcation lesion market estimates and forecast by application (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing &forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Bifurcation lesions market summary 2016 (USD Million)
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT Analysis, by factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces analysis
  • FIG. 15 Bifurcation lesions competitive landscape: Market position analysis (based on procedures, regional presence)
  • FIG. 16 Bifurcation lesions market, application outlook key takeaways
  • FIG. 17 Bifurcation lesions application movement analysis
  • FIG. 18 Coronary vascular bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 19 Peripheral vascular bifurcation lesions market, 2014 - 2024 (USD Million)
  • FIG. 20 Regional market place: Key takeaways
  • FIG. 21 Bifurcation lesions market: Regional movement analysis
  • FIG. 22 North America bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 23 The U.S. bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 24 Canada bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 25 Europe bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 26 Germany bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 27 The UK bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 28 Asia Pacific bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 29 Japan bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 30 China bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 31 Latin America bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 32 Brazil bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 33 Mexico bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 34 MEA bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 35 South Africa bifurcation lesions market, 2014 - 2025 (USD Million)
  • FIG. 36 Competitive strategy adopted by leading players
Back to Top